UFPT vs. PLSE, IRMD, SPNE, UTMD, ARAY, SON, SEE, PKG, GPK, and PEN
Should you be buying UFP Technologies stock or one of its competitors? The main competitors of UFP Technologies include Pulse Biosciences (PLSE), Iradimed (IRMD), SeaSpine (SPNE), Utah Medical Products (UTMD), Accuray (ARAY), Sonoco Products (SON), Sealed Air (SEE), Packaging Co. of America (PKG), Graphic Packaging (GPK), and Penumbra (PEN).
UFP Technologies (NASDAQ:UFPT) and Pulse Biosciences (NASDAQ:PLSE) are both small-cap industrial products companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, community ranking, valuation, risk, media sentiment and analyst recommendations.
In the previous week, Pulse Biosciences had 2 more articles in the media than UFP Technologies. MarketBeat recorded 5 mentions for Pulse Biosciences and 3 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 1.68 beat Pulse Biosciences' score of 0.58 indicating that UFP Technologies is being referred to more favorably in the media.
UFP Technologies has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.73, meaning that its share price is 73% more volatile than the S&P 500.
Pulse Biosciences received 41 more outperform votes than UFP Technologies when rated by MarketBeat users. Likewise, 65.17% of users gave Pulse Biosciences an outperform vote while only 59.03% of users gave UFP Technologies an outperform vote.
UFP Technologies has a net margin of 11.75% compared to Pulse Biosciences' net margin of 0.00%. UFP Technologies' return on equity of 17.40% beat Pulse Biosciences' return on equity.
UFP Technologies has higher revenue and earnings than Pulse Biosciences. Pulse Biosciences is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.
87.3% of UFP Technologies shares are owned by institutional investors. Comparatively, 77.0% of Pulse Biosciences shares are owned by institutional investors. 6.2% of UFP Technologies shares are owned by insiders. Comparatively, 71.5% of Pulse Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
UFP Technologies currently has a consensus target price of $238.50, indicating a potential downside of 8.40%. Given UFP Technologies' higher probable upside, analysts plainly believe UFP Technologies is more favorable than Pulse Biosciences.
Summary
UFP Technologies beats Pulse Biosciences on 11 of the 17 factors compared between the two stocks.
Get UFP Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for UFPT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding UFPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
UFP Technologies Competitors List
Related Companies and Tools
